Os Therapies Incorporated Stock Current Valuation
| OSTX Stock | 3.02 1.44 32.29% |
Valuation analysis of OS Therapies helps investors to measure OS Therapies' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, OS Therapies' Cash is fairly stable compared to the past year. End Period Cash Flow is likely to rise to about 77.7 K in 2024, whereas Change In Cash is likely to drop (139.1 K) in 2024. Fundamental drivers impacting OS Therapies' valuation include:
Enterprise Value 90.7 M |
Undervalued
Today
Please note that OS Therapies' price fluctuation is very risky at this time. Calculation of the real value of OS Therapies is based on 3 months time horizon. Increasing OS Therapies' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since OS Therapies is currently traded on the exchange, buyers and sellers on that exchange determine the market value of OSTX Stock. However, OS Therapies' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.02 | Real 5.9 | Target 15.0 | Hype 2.97 |
The intrinsic value of OS Therapies' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence OS Therapies' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of OS Therapies Incorporated helps investors to forecast how OSTX stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OS Therapies more accurately as focusing exclusively on OS Therapies' fundamentals will not take into account other important factors: OS Therapies Incorporated Company Current Valuation Analysis
OS Therapies' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current OS Therapies Current Valuation | 90.74 M |
Most of OS Therapies' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OS Therapies Incorporated is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
OSTX Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for OS Therapies is extremely important. It helps to project a fair market value of OSTX Stock properly, considering its historical fundamentals such as Current Valuation. Since OS Therapies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of OS Therapies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of OS Therapies' interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, OS Therapies Incorporated has a Current Valuation of 90.74 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is notably lower than that of the firm.
OSTX Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OS Therapies' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OS Therapies could also be used in its relative valuation, which is a method of valuing OS Therapies by comparing valuation metrics of similar companies.OS Therapies is currently under evaluation in current valuation category among its peers.
OSTX Fundamentals
| Current Valuation | 90.74 M | ||||
| Shares Outstanding | 20.88 M | ||||
| Shares Owned By Insiders | 24.83 % | ||||
| Number Of Shares Shorted | 8.93 K | ||||
| EBITDA | (3.18 M) | ||||
| Net Income | (7.79 M) | ||||
| Total Debt | 14.61 M | ||||
| Book Value Per Share | (4.52) X | ||||
| Cash Flow From Operations | (3.01 M) | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | (0.32) X | ||||
| Target Price | 15.0 | ||||
| Market Capitalization | 74.14 M | ||||
| Total Asset | 798.08 K | ||||
| Retained Earnings | (29.52 M) | ||||
| Working Capital | (23.92 M) | ||||
| Net Asset | 798.08 K |
About OS Therapies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OS Therapies Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OS Therapies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OS Therapies Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for OSTX Stock Analysis
When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.